Get the Stockscreener App
3.7514
1.48%
0.0414
Outset Medical Inc stock is traded at $3.7514, with a volume of 185.94K.
It is up +1.48% in the last 24 hours and down -7.04% over the past month.
Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.
See More
Previous Close:
$3.71
Open:
$3.74
24h Volume:
185.94K
Relative Volume:
0.37
Market Cap:
$68.07M
Revenue:
$114.73M
Net Income/Loss:
$-140.94M
P/E Ratio:
-1.3592
EPS:
-2.76
Net Cash Flow:
$-126.18M
1W Performance:
+12.05%
1M Performance:
-7.04%
6M Performance:
-81.71%
1Y Performance:
-78.55%
1-Day Range:
$3.625
$3.888
1-Week Range:
$3.22
$3.888
52-Week Range:
$3.10
$25.35
Outset Medical Inc Stock (OM) Company Profile
Name
Outset Medical Inc
Sector
Industry
Phone
669-231-8200
Address
3052 ORCHARD DRIVE, SAN JOSE
Compare OM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OM
Outset Medical Inc
|
3.75 | 67.35M | 114.73M | -140.94M | -126.18M | -2.76 |
|
ABT
Abbott Laboratories
|
124.35 | 217.86B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
94.89 | 141.35B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
348.82 | 134.41B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
96.27 | 123.15B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.26 | 49.47B | 5.88B | 1.34B | 799.60M | 2.3489 |
Outset Medical Inc Stock (OM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-08-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jun-21-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Apr-08-24 | Initiated | BTIG Research | Buy |
| Apr-05-24 | Upgrade | CL King | Neutral → Buy |
| Jan-12-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Oct-13-23 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-17-23 | Initiated | CL King | Neutral |
| Nov-11-22 | Initiated | RBC Capital Mkts | Outperform |
| Jul-14-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-17-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-18-21 | Initiated | Cowen | Outperform |
| Apr-19-21 | Initiated | Wells Fargo | Overweight |
| Dec-16-20 | Initiated | Oppenheimer | Perform |
| Oct-12-20 | Initiated | Barclays | Overweight |
| Oct-12-20 | Initiated | BofA Securities | Buy |
| Oct-12-20 | Initiated | Goldman | Buy |
| Oct-12-20 | Initiated | Morgan Stanley | Equal-Weight |
| Oct-12-20 | Initiated | SVB Leerink | Mkt Perform |
| Oct-12-20 | Initiated | Stifel | Buy |
View All
Outset Medical Inc Stock (OM) Latest News
2026-01-01 | Outset Medical, Inc. (OM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation | NDAQ:OM | Press Release - Stockhouse
Outset Medical, Inc. (NASDAQ:OM) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Nasdaq Moves: Why Outset Medical Inc. stock is favored by pension fundsWeekly Market Summary & Safe Swing Trade Setup Alerts - moha.gov.vn
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Outset Medical, Inc.OM - FinancialContent
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Outset Medical, Inc. (OM) And Encourages Shareholders to Reach Out - ACCESS Newswire
2025-12-29 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Outset Medical, Inc. (OM) And Encourages Shareholders to Reach Out | NDAQ:OM | Press Release - Stockhouse
Pullback Watch: Why Outset Medical Inc stock could rally in 2025Swing Trade & Real-Time Sentiment Analysis - moha.gov.vn
Outset Medical’s Q3 2025 Earnings and Outlook - MSN
Outset Medical, Inc. (OM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Nasdaq Moves: How Potbelly Corporation stock reacts to oil pricesMarket Movement Recap & Reliable Intraday Trade Alerts - moha.gov.vn
Bronstein, Gewirtz & Grossman, LLC Is Investigating Outset Medical, Inc. (OM) And Encourages Investors to Connect - ACCESS Newswire
Outset Medical (OM) Price Target Decreased by 38.83% to 16.06 - MSN
Outset Medical Earnings Notes - Trefis
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Outset Medical, Inc. (OM) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
377,033 Shares in Outset Medical, Inc. $OM Bought by Assenagon Asset Management S.A. - MarketBeat
CEO Moves: How Outset Medical Inc. stock reacts to inflationary pressuresDip Buying & Detailed Earnings Play Alerts - Улправда
Earnings Recap: Why retail investors pile into Outset Medical Inc. stockJuly 2025 Snapshot & Fast Gain Stock Trading Tips - Улправда
Why retail investors pile into Outset Medical Inc. stockQuarterly Trade Review & Risk Managed Investment Strategies - Улправда
Why Outset Medical Inc. stock could rally in 2025Weekly Investment Report & Long Hold Capital Preservation Tips - Улправда
Quarterly Trades: How Outset Medical Inc. stock reacts to inflationary pressuresJuly 2025 Fed Impact & Long-Term Safe Investment Plans - Улправда
How Outset Medical Inc. stock reacts to inflationary pressures2025 AllTime Highs & Real-Time Chart Pattern Alerts - Улправда
Is Outset Medical Inc. stock supported by innovation pipelineMarket Trend Summary & High Conviction Buy Zone Picks - Улправда
Will Outset Medical Inc. stock see insider buyingQuarterly Profit Summary & Low Risk Growth Stock Ideas - Улправда
Portfolio Shifts: Will Outset Medical Inc. stock see insider buyingJuly 2025 Volume & Weekly Return Optimization Plans - Улправда
Why Outset Medical Inc. stock is trending among retail tradersMarket Activity Report & Weekly Stock Breakout Alerts - Улправда
Big Picture: Can Outset Medical Inc. stock deliver strong Q4 earningsPortfolio Value Report & Verified Momentum Stock Watchlist - Улправда
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Outset Medical, Inc. (OM) And Encourages Investors to Reach Out - ACCESS Newswire
How Outset Medical Inc. stock compares to market leadersWeekly Gains Report & Real-Time Stock Price Movement Reports - DonanımHaber
Why analysts remain bullish on Outset Medical Inc. stockJuly 2025 Snapshot & Technical Confirmation Trade Alerts - DonanımHaber
Is Outset Medical Inc. stock cheap compared to fundamentals2025 EndofYear Setup & Free High Accuracy Swing Entry Alerts - DonanımHaber
How Outset Medical Inc. stock compares to industry benchmarks2025 Support & Resistance & AI Powered Market Trend Analysis - DonanımHaber
The Market Doesn't Like What It Sees From Outset Medical, Inc.'s (NASDAQ:OM) Revenues Yet As Shares Tumble 27% - simplywall.st
Aug Movers: Can Outset Medical Inc. stock deliver strong Q4 earningsJuly 2025 Short Interest & Free Expert Verified Stock Movement Alerts - Улправда
Will Outset Medical Inc. stock deliver shareholder valueTrade Entry Report & Weekly Stock Performance Updates - DonanımHaber
Risk Recap: Can Outset Medical Inc. stock deliver strong Q4 earningsTrend Reversal & Smart Allocation Stock Reports - Улправда
Winners Losers: Why Outset Medical Inc. stock is trending among retail tradersMarket Risk Summary & Free Fast Gain Swing Trade Alerts - Улправда
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Outset Medical, Inc. (OM) And Encourages Stockholders to Reach Out - ACCESS Newswire
Outset Medical, Inc. (OM) Reports Q3 Loss, Lags Revenue Estimates - MSN
RBC Adjusts Price Target on Outset Medical to $7 From $17, Maintains Sector Perform Rating - marketscreener.com
BTIG Remains a Buy on Outset Medical (OM) - The Globe and Mail
BTIG reiterates Buy rating on Outset Medical stock, maintains $17 target By Investing.com - Investing.com South Africa
Outset Medical's (OM) Buy Rating Reiterated at BTIG Research - MarketBeat
BTIG reiterates Buy rating on Outset Medical stock, maintains $17 target - Investing.com Australia
BTIG Reiterates Buy Rating for Outset Medical (OM) with Price Ta - GuruFocus
BTIG Reiterates Buy Rating on Outset Medical Inc. (OM) - StreetInsider
Outset Medical (NASDAQ:OM) Upgraded to "Hold" at Wall Street Zen - MarketBeat
Why Did Outset Medical Stock Tumble Today? - MSN
Aug Setups: How Outset Medical Inc stock compares to industry benchmarksQuarterly Portfolio Summary & Scalable Portfolio Growth Methods - moha.gov.vn
Geode Capital Management LLC Has $7.98 Million Stock Holdings in Outset Medical, Inc. $OM - MarketBeat
Outset Medical, Inc. (NASDAQ:OM) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Outset Medical Shares Continue to Face Sustained Selling Pressure - AD HOC NEWS
Outset Medical Inc Stock (OM) Financials Data
Revenue
Net Income
Cash Flow
EPS
Outset Medical Inc Stock (OM) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Trigg Leslie | Chair and CEO |
Nov 17 '25 |
Sale |
4.60 |
916 |
4,214 |
121,412 |
| Nash Marc | EVP Operations R&D & Service |
Nov 17 '25 |
Sale |
4.60 |
247 |
1,136 |
48,268 |
| Brottem John L. | General Counsel |
Nov 17 '25 |
Sale |
4.60 |
388 |
1,785 |
46,495 |
0.18%
1.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):